Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,634.25
1,890.53
2,456.37
2,635.41
1,922.08
1,409.20
997.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,634.25
1,890.53
2,456.37
2,635.41
1,922.08
1,409.20
997.62
Raw Material Cost
581.11
448.11
480.60
432.83
305.16
212.40
164.39
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
339.20
256.08
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
64.22
55.29
36.51
14.55
1.29
0.23
0.14
Selling and Distribution Expenses
857.84
754.79
815.83
715.30
575.24
525.81
379.30
Other Expenses
13.44
15.63
19.79
14.91
7.64
-27.28
-21.14
Total Expenditure (Excl Depreciation)
1,637.62
1,414.49
1,530.84
1,311.75
958.06
804.81
588.49
Operating Profit (PBDIT) excl Other Income
996.5999999999999
476
925.5
1323.7
964
604.4
409.09999999999997
Other Income
79.55
124.47
135.92
99.50
69.74
68.25
64.42
Operating Profit (PBDIT)
1,219.51
716.36
1,143.82
1,481.84
1,072.61
703.68
495.68
Interest
64.22
55.29
36.51
14.55
1.29
0.23
0.14
Exceptional Items
-4.17
-27.07
-7.88
-1.33
-0.48
-1.35
-0.22
Gross Profit (PBDT)
2,053.14
1,442.43
1,975.77
2,202.59
1,616.92
1,196.80
833.23
Depreciation
144.15
112.98
82.62
58.74
38.89
30.81
22.18
Profit Before Tax
1,006.96
521.02
1,016.81
1,407.22
1,031.95
671.28
473.14
Tax
192.78
95.30
135.86
211.38
158.95
102.59
72.19
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
820.20
436.49
889.56
1,196.81
875.24
570.82
401.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
820.20
436.49
889.56
1,196.81
875.24
570.82
401.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-6.01
-10.77
-8.62
-0.97
-2.24
-2.13
-1.03
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
814.19
425.72
880.95
1,195.84
873.00
568.69
400.95
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,333.91
3,147.48
3,574.29
3,358.86
2,806.79
2,142.47
1,701.79
Earnings per share (EPS)
1.08
0.56
1.11
1.49
1.08
0.72
0.51
Diluted Earnings per share
1.08
0.56
1.11
1.49
1.08
0.72
0.51
Operating Profit Margin (Excl OI)
37.8%
25.33%
37.67%
50.22%
50.15%
42.91%
41.01%
Gross Profit Margin
43.7%
33.54%
44.76%
55.63%
55.71%
49.82%
49.65%
PAT Margin
31.14%
23.09%
36.21%
45.41%
45.54%
40.51%
40.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 39.34% vs -23.04% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 91.26% vs -51.67% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 92.60% vs -41.27% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 16.09% vs 51.51% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Jafron Biomedical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
2,634.25
0
2,634.25
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,634.25
0
2,634.25
Raw Material Cost
581.11
0
581.11
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
64.22
0
64.22
Selling and Distribution Expenses
857.84
0
857.84
Other Expenses
13.44
0.00
13.44
Total Expenditure (Excl Depreciation)
1,637.62
0
1,637.62
Operating Profit (PBDIT) excl Other Income
996.63
0.00
996.63
Other Income
79.55
0
79.55
Operating Profit (PBDIT)
1,219.51
0
1,219.51
Interest
64.22
0
64.22
Exceptional Items
-4.17
0
-4.17
Gross Profit (PBDT)
2,053.14
0
2,053.14
Depreciation
144.15
0
144.15
Profit Before Tax
1,006.96
0
1,006.96
Tax
192.78
0
192.78
Provisions and contingencies
0
0
0.00
Profit After Tax
820.20
0
820.20
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
820.20
0
820.20
Share in Profit of Associates
0
0
0.00
Minority Interest
-6.01
0
-6.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
814.19
0
814.19
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,333.91
0
3,333.91
Earnings per share (EPS)
1.08
0
1.08
Diluted Earnings per share
1.08
0
1.08
Operating Profit Margin (Excl OI)
37.80%
0%
0.00
37.80%
Gross Profit Margin
43.70%
0%
0.00
43.70%
PAT Margin
31.14%
0%
0.00
31.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 263.42 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 39.34% vs -23.04% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 81.42 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 91.26% vs -51.67% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 114.00 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 92.60% vs -41.27% in Dec 2023
Annual - Interest
Interest 6.42 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 16.09% vs 51.51% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.80%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






